Skip to main content
SpringerLink
Log in

Assessment and Treatment of Cardiovascular Disease in Obese Children

  • Chapter
  • First Online:
Management of Pediatric Obesity and Diabetes

Part of the book series: Nutrition and Health ((NH))

  • 1760 Accesses

Key Points

Pediatric obesity predicts adult obesity, unfortunately. Pediatric obesity is linked to early development of elevated risk for subsequent cardiovascular disease. Obese children and adolescents deserve comprehensive, cardiovascular risk assessment. Interventions to promote healthier nutrition and increased physical activity remain the mainstays for prevention, treatment, and ultimate risk reduction.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

ReferenceS

  1. Alaupovic P (1981) David Rubinstein memorial lecture: the biochemical and clinical significance of the interrelationship between very low density and high density lipoproteins. Can J Biochem 59:565–579

    PubMed  CAS  Google Scholar 

  2. Alaupovic P, Blackett P, Wang W, Lee E (2008) Characterization of the metabolic syndrome by apolipoproteins in the Oklahoma Cherokee. J Cardiometab Syndr 3:193–199

    PubMed  Google Scholar 

  3. Altomonte J, Cong L, Harbaran S et al. (2004) Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. J Clin Invest 114:1493–1503

    PubMed  CAS  Google Scholar 

  4. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV (1986) Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 315:215–219

    PubMed  CAS  Google Scholar 

  5. Anuurad E, Chiem A, Pearson TA, Berglund L (2007) Metabolic syndrome components in African-Americans and European-American patients and its relation to coronary artery disease. Am J Cardiol 100:830–834

    PubMed  Google Scholar 

  6. Aronson D (2008) Hyperglycemia and the pathobiology of diabetic complications. Adv Cardiol 45:1–16

    PubMed  CAS  Google Scholar 

  7. Arslanian S, Suprasongsin C (1996) Insulin sensitivity, lipids, and body composition in childhood: is “syndrome X” present? J Clin Endocrinol Metab 81:1058–1062

    PubMed  CAS  Google Scholar 

  8. Atabek ME, Pirgon O, Kivrak AS (2007) Evidence for association between insulin resistance and premature carotid atherosclerosis in childhood obesity. Pediatr Res 61:345–349

    PubMed  CAS  Google Scholar 

  9. Austin MA (2000) Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype. Curr Atheroscler Rep 2:200–207

    PubMed  CAS  Google Scholar 

  10. Back MR, Carew TE, Schmid-Schoenbein GW (1995) Deposition pattern of monocytes and fatty streak development in hypercholesterolemic rabbits. Atherosclerosis 116:103–115

    PubMed  CAS  Google Scholar 

  11. Bank AJ, Wang H, Holte JE, Mullen K, Shammas R, Kubo SH (1996) Contribution of collagen, elastin, and smooth muscle to in vivo human brachial artery wall stress and elastic modulus. Circulation 94:3263–3270

    PubMed  CAS  Google Scholar 

  12. Barlow SE, Dietz WH (1998) Obesity evaluation and treatment: Expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services. Pediatrics 102:E29

    PubMed  CAS  Google Scholar 

  13. Bayrak A, Aldemir DA, Bayrak T, Corakci A, Dursun P (2006) The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women. Arch Gynecol Obstet 274:289–296

    PubMed  CAS  Google Scholar 

  14. Beauloye V, Zech F, Tran HT, Clapuyt P, Maes M, Brichard SM (2007) Determinants of early atherosclerosis in obese children and adolescents. J Clin Endocrinol Metab 92:3025–3032

    PubMed  CAS  Google Scholar 

  15. Begum N, Song Y, Rienzie J, Ragolia L (1998) Vascular smooth muscle cell growth and insulin regulation of mitogen-activated protein kinase in hypertension. Am J Physiol 275:C42–C49

    PubMed  CAS  Google Scholar 

  16. Berenson G, Srinivasan S, Chen W, Li S, Patel D (2006) Racial (black-white) contrasts of risk for hypertensive disease in youth have implications for preventive care: the Bogalusa Heart Study. Ethn Dis 16:S4-2-9

    Google Scholar 

  17. Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE, Wattigney WA (1998) Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338:1650–1656

    PubMed  CAS  Google Scholar 

  18. Berkowitz RI, Fujioka K, Daniels SR et al. (2006) Effects of sibutramine treatment in obese adolescents: a randomized trial. Ann Intern Med 145:81–90

    PubMed  CAS  Google Scholar 

  19. Blackett PR, Blevins KS, Quintana E et al. (2005) ApoC-III bound to apoB-containing lipoproteins increase with insulin resistance in Cherokee Indian youth. Metabolism 54:180–187

    PubMed  CAS  Google Scholar 

  20. Blackett PR, Blevins KS, Stoddart M et al. (2005) Body mass index and high-density lipoproteins in Cherokee Indian children and adolescents. Pediatr Res 58:472–477

    PubMed  CAS  Google Scholar 

  21. Blackett PR, Taylor T, Russell D, Lu M, Fesmire J, Lee ET (1996) Lipoprotein changes in relation to body mass index in Native American adolescents. Pediatr Res 40:77–81

    PubMed  CAS  Google Scholar 

  22. Blankenberg S, Barbaux S, Tiret L (2003) Adhesion molecules and atherosclerosis. Atherosclerosis 170:191–203

    PubMed  CAS  Google Scholar 

  23. Boney CM, Verma A, Tucker R, Vohr BR (2005) Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115:e290–e296

    PubMed  Google Scholar 

  24. Brambilla P, Lissau I, Flodmark CE et al. (2007) Metabolic risk-factor clustering estimation in children: to draw a line across pediatric metabolic syndrome. Int J Obes (Lond) 31:591–600

    CAS  Google Scholar 

  25. Burns SF, Arslanian SA (2009) Waist circumference, atherogenic lipoproteins, and vascular smooth muscle biomarkers in children. J Clin Endocrinol Metab 94:4914–4922

    PubMed  CAS  Google Scholar 

  26. Cali AM, Zern TL, Taksali SE et al. (2007) Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect pro-atherogenic state. Diab Care 30(12):3093–3098

    CAS  Google Scholar 

  27. Cardoso-Saldana G, Juarez-Rojas JG, Zamora-Gonzalez J et al. (2007) C-reactive protein levels and their relationship with metabolic syndrome and insulin resistance in Mexican adolescents. J Pediatr Endocrinol Metab 20:797–805

    PubMed  CAS  Google Scholar 

  28. Carr MC, Brunzell JD (2004) Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 89:2601–2607

    PubMed  CAS  Google Scholar 

  29. Cassidy AE, Bielak LF, Zhou Y et al. (2005) Progression of subclinical coronary atherosclerosis: does obesity make a difference? Circulation 111:1877–1882

    PubMed  Google Scholar 

  30. Chait A, Wight TN (2000) Interaction of native and modified low-density lipoproteins with extracellular matrix. Curr Opin Lipidol 11:457–463

    PubMed  CAS  Google Scholar 

  31. Chajek T, Eisenberg S (1978) Very low density lipoprotein. Metabolism of phospholipids, cholesterol, and apolipoprotein C in the isolated perfused rat heart. J Clin Invest 61:1654–1665

    PubMed  CAS  Google Scholar 

  32. Chan SY, Mancini GB, Burns S et al. (2006) Dietary measures and exercise training contribute to improvement of endothelial function and atherosclerosis even in patients given intensive pharmacologic therapy. J Cardiopulm Rehabil 26:288–293

    PubMed  Google Scholar 

  33. Clark LT, El-Atat F (2007) Metabolic syndrome in African Americans: implications for preventing coronary heart disease. Clin Cardiol 30:161–164

    PubMed  Google Scholar 

  34. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH (2003) Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 157:821–827

    PubMed  Google Scholar 

  35. Copeland KC, Eichberg JW, Parker CR Jr (1985) Bartke A: Puberty in the chimpanzee: somatomedin-C and its relationship to somatic growth and steroid hormone concentrations. J Clin Endocrinol Metab 60:1154–1160

    PubMed  CAS  Google Scholar 

  36. Copeland KC, Kuehl TJ, Castracane VD (1982) Pubertal endocrinology of the baboon: elevated somatomedin-C/insulin-like growth factor I at puberty. J Clin Endocrinol Metab 55:1198–1201

    PubMed  CAS  Google Scholar 

  37. Cromwell WC, Barringer TA (2009) Low-density lipoprotein and apolipoprotein B: clinical use in patients with coronary heart disease. Curr Cardiol Rep 11:468–475

    PubMed  Google Scholar 

  38. Cromwell WC, Otvos JD (2006) Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl. Am J Cardiol 98:1599–1602

    PubMed  CAS  Google Scholar 

  39. Cromwell WC, Otvos JD, Keyes MJ et al. (2007) LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study – implications for LDL management. J Clin Lipidol 1:583–592

    PubMed  Google Scholar 

  40. Cruz ML, Goran MI (2004) The metabolic syndrome in children and adolescents. Curr Diab Rep 4:53–62

    PubMed  Google Scholar 

  41. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI (2004) The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 89:108–113

    PubMed  CAS  Google Scholar 

  42. Dallongeville J, Lussier-Cacan S, Davignon J (1992) Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res 33:447–454

    PubMed  CAS  Google Scholar 

  43. Danesh J, Collins R, Peto R (2000) Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 102:1082–1085

    PubMed  CAS  Google Scholar 

  44. Daniels SR, Kimball TR, Morrison JA, Khoury P, Witt S, Meyer RA (1995) Effect of lean body mass, fat mass, blood pressure, and sexual maturation on left ventricular mass in children and adolescents. Statistical, biological, and clinical significance. Circulation 92:3249–3254

    PubMed  CAS  Google Scholar 

  45. Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1–21

    PubMed  CAS  Google Scholar 

  46. Davis PH, Dawson JD, Riley WA, Lauer RM (2001) Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation 104:2815–2819

    PubMed  CAS  Google Scholar 

  47. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N (2004) Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 110:2494–2497

    PubMed  Google Scholar 

  48. de Groot E, Hovingh GK, Wiegman A et al. (2004) Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 109:III33–III38

    Google Scholar 

  49. Dekkers C, Treiber FA, Kapuku G, Van Den Oord EJ, Snieder H (2002) Growth of left ventricular mass in African American and European American youth. Hypertension 39:943–951

    PubMed  CAS  Google Scholar 

  50. Desideri G, De Simone M, Iughetti L et al. (2005) Early activation of vascular endothelial cells and platelets in obese children. J Clin Endocrinol Metab 90:3145–3152

    PubMed  CAS  Google Scholar 

  51. Dunder K, Lind L, Zethelius B, Berglund L, Lithell H (2004) Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM). Am Heart J 148:596–601

    PubMed  CAS  Google Scholar 

  52. Enos WF, Holmes RH, Beyer J (1986) Landmark article, July 18, 1953: Coronary disease among United States soldiers killed in action in Korea. Preliminary report. By William F. Enos, Robert H. Holmes and James Beyer. JAMA 256:2859–2862

    PubMed  CAS  Google Scholar 

  53. Fernandez JR, Redden DT, Pietrobelli A, Allison DB (2004) Waist circumference ­percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 145:439–444

    PubMed  Google Scholar 

  54. Fernandez N, Martinez MA, Climent B et al. (2003) In vivo coronary effects of endothelin-1 after ischemia-reperfusion. Role of nitric oxide and prostanoids. Eur J Pharmacol 481:109–117

    PubMed  CAS  Google Scholar 

  55. Flynn JT, Daniels SR (2006) Pharmacologic treatment of hypertension in children and adolescents. J Pediatr 149:746–754

    PubMed  CAS  Google Scholar 

  56. Freedman DS, Bowman BA, Otvos JD, Srinivasan SR, Berenson GS (2000) Levels and correlates of LDL and VLDL particle sizes among children: the Bogalusa heart study. Atherosclerosis 152:441–449

    PubMed  CAS  Google Scholar 

  57. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS (1999) The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics 103:1175–1182

    PubMed  CAS  Google Scholar 

  58. Freedman DS, Kahn HS, Mei Z et al. (2007) Relation of body mass index and waist-to-height ratio to cardiovascular disease risk factors in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr 86:33–40

    PubMed  CAS  Google Scholar 

  59. Freedman DS, Khan LK, Dietz WH, Srinivasan SR, Berenson GS (2001) Relationship of childhood obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study. Pediatrics 108:712–718

    PubMed  CAS  Google Scholar 

  60. Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR, Berenson GS (2005) The relation of childhood BMI to adult adiposity: the Bogalusa Heart Study. Pediatrics 115:22–27

    PubMed  Google Scholar 

  61. Freemark M (2007) Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach. Diab Care 30:395–402

    CAS  Google Scholar 

  62. Giannini C, de Giorgis T, Scarinci A et al. (2007) Obese related effects of inflammatory markers and insulin resistance on increased carotid intima media thickness in pre-pubertal children. Atherosclerosis 200(2):446

    Google Scholar 

  63. Gilardini L, Parati G, Sartorio A, Mazzilli G (2007) Pontiggia B. Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity. J Hum Hypertens, Invitti C

    Google Scholar 

  64. Ginsberg HN (2002) New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism. Circulation 106:2137–2142

    PubMed  Google Scholar 

  65. Ginsberg HN, Zhang YL, Hernandez-Ono A (2005) Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 36:232–240

    PubMed  CAS  Google Scholar 

  66. Glowinska B, Urban M, Hryniewicz A, Peczynska J, Florys B, Al-Hwish M (2004) Endothelin-1 plasma concentration in children and adolescents with atherogenic risk factors. Kardiol Pol 61:329–338

    PubMed  Google Scholar 

  67. Glowinska B, Urban M, Peczynska J, Florys B (2005) Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Metabolism 54:1020–1026

    PubMed  CAS  Google Scholar 

  68. Goran MI (1999) Visceral fat in prepubertal children: Influence of obesity, anthropometry, ethnicity, gender, diet, and growth. Am J Hum Biol 11:201–207

    PubMed  Google Scholar 

  69. Graves JW, Althaf MM (2006) Utility of ambulatory blood pressure monitoring in children and adolescents. Pediatr Nephrol 21:1640–1652

    PubMed  Google Scholar 

  70. Grundy SM (2007) Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 92:399–404

    PubMed  CAS  Google Scholar 

  71. Gunnell DJ, Frankel SJ, Nanchahal K, Peters TJ, Davey Smith G (1998) Childhood obesity and adult cardiovascular mortality: a 57-y follow-up study based on the Boyd Orr cohort. Am J Clin Nutr 67:1111–1118

    PubMed  CAS  Google Scholar 

  72. Haji SA, Ulusoy RE, Patel DA et al. (2006) Predictors of left ventricular dilatation in young adults (from the Bogalusa Heart Study). Am J Cardiol 98:1234–1237

    PubMed  Google Scholar 

  73. Hannon TS, Bacha F, Lee SJ, Janosky J, Arslanian SA (2006) Use of markers of dyslipidemia to identify overweight youth with insulin resistance. Pediatr Diabetes 7:260–266

    PubMed  Google Scholar 

  74. Hannon TS, Janosky J, Arslanian SA (2006) Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res 60:759–763

    PubMed  CAS  Google Scholar 

  75. Hironaka K, Yano M, Kohno M et al. (1997) In vivo aortic wall characteristics at the early stage of atherosclerosis in rabbits. Am J Physiol 273:H1142–H1147

    PubMed  CAS  Google Scholar 

  76. Hirschler V, Acebo HL, Fernandez GB, de Lujan Calcagno M, Gonzalez C, Jadzinsky M (2006) Influence of obesity and insulin resistance on left atrial size in children. Pediatr Diabetes 7:39–44

    PubMed  Google Scholar 

  77. Hixson JE (1991) Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological determinants of atherosclerosis in youth (PDAY) research group. Arterioscler Thromb 11:1237–1244

    PubMed  CAS  Google Scholar 

  78. Hodge AM, Dowse GK, Zimmet PZ, Collins VR (1995) Prevalence and secular trends in obesity in Pacific and Indian Ocean island populations. Obes Res 3(Suppl 2):77s–87s

    PubMed  Google Scholar 

  79. Hodis HN, Mack WJ, Azen SP et al. (1994) Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation 90:42–49

    PubMed  CAS  Google Scholar 

  80. Hotamisligil GS (2003) Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 27(Suppl 3):S53–S55

    PubMed  CAS  Google Scholar 

  81. Iannuzzi A, Licenziati MR, Acampora C et al. (2006) Carotid artery stiffness in obese children with the metabolic syndrome. Am J Cardiol 97:528–531

    PubMed  Google Scholar 

  82. Iglseder B, Mackevics V, Stadlmayer A, Tasch G, Ladurner G, Paulweber B (2005) Plasma adiponectin levels and sonographic phenotypes of subclinical carotid artery atherosclerosis: data from the SAPHIR Study. Stroke 36:2577–2582

    PubMed  CAS  Google Scholar 

  83. Ikewaki K, Zech LA, Kindt M, Brewer HB Jr, Rader DJ (1995) Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans. Arterioscler Thromb Vasc Biol 15:306–312

    PubMed  CAS  Google Scholar 

  84. Inge T, Wilson KA, Gamm K, Kirk S, Garcia VF, Daniels SR (2007) Preferential loss of central (trunk) adiposity in adolescents and young adults after laparoscopic gastric bypass. Surg Obes Relat Dis 3:153–158

    PubMed  Google Scholar 

  85. Ito N, Ohishi M, Takagi T et al. (2006) Clinical usefulness and limitations of brachial-ankle pulse wave velocity in the evaluation of cardiovascular complications in hypertensive patients. Hypertens Res 29:989–995

    PubMed  Google Scholar 

  86. Jemaa R, Elasmi M, Naouali C et al. (2006) Apolipoprotein E polymorphism in the Tunisian population: frequency and effect on lipid parameters. Clin Biochem 39:816–820

    PubMed  CAS  Google Scholar 

  87. Jeyarajah EJ, Cromwell WC, Otvos JD (2006) Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 26:847–870

    PubMed  Google Scholar 

  88. Jolliffe CJ, Janssen I (2007) Development of age-specific adolescent metabolic syndrome criteria that are linked to the Adult Treatment Panel III and International Diabetes Federation criteria. J Am Coll Cardiol 49:891–898

    PubMed  Google Scholar 

  89. Jones GT, van Rij AM, Cole J et al. (2007) Plasma lipoprotein(a) indicates risk for 4 distinct forms of vascular disease. Clin Chem 53:679–685

    PubMed  CAS  Google Scholar 

  90. Jones KL (2006) The dilemma of the metabolic syndrome in children and adolescents: disease or distraction? Pediatr Diabetes 7:311–321

    PubMed  Google Scholar 

  91. Juonala M, Viikari JS, Ronnemaa T, Taittonen L, Marniemi J, Raitakari OT (2006) Childhood C-reactive protein in predicting CRP and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol 26:1883–1888

    PubMed  CAS  Google Scholar 

  92. Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diab Care 28:2289–2304

    Google Scholar 

  93. Kapiotis S, Holzer G, Schaller G et al. (2006) A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arterioscler Thromb Vasc Biol 26:2541–2546

    PubMed  CAS  Google Scholar 

  94. Kappes A, Loffler G (2000) Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes. Horm Metab Res 32:548–554

    PubMed  CAS  Google Scholar 

  95. Kawakami A, Aikawa M, Libby P, Alcaide P, Luscinskas FW, Sacks FM (2006) Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells. Circulation 113:691–700

    PubMed  CAS  Google Scholar 

  96. Kelly AS, Steinberger J, Kaiser DR, Olson TP, Bank AJ, Dengel DR (2006) Oxidative stress and adverse adipokine profile characterize the metabolic syndrome in children. J Cardiometab Syndr 1:248–252

    PubMed  Google Scholar 

  97. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280:E745–E751

    PubMed  CAS  Google Scholar 

  98. Kissebah AH, Vydelingum N, Murray R et al. (1982) Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54:254–260

    PubMed  CAS  Google Scholar 

  99. Koeijvoets KC, Rodenburg J, Hutten BA, Wiegman A, Kastelein JJ, Sijbrands EJ (2005) Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia: substudy of an intima-media thickness trial. Circulation 112:3168–3173

    PubMed  CAS  Google Scholar 

  100. Kortelainen ML, Sarkioja T (2001) Visceral fat and coronary pathology in male adolescents. Int J Obes Relat Metab Disord 25:228–232

    PubMed  CAS  Google Scholar 

  101. Kurl S, Laukkanen JA, Niskanen L et al. (2006) Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 37:806–811

    PubMed  Google Scholar 

  102. Kwiterovich PO Jr (2008) Recognition and management of dyslipidemia in children and adolescents. J Clin Endocrinol Metab 93:4200–4209

    PubMed  CAS  Google Scholar 

  103. Lee JW, Lee DC, Im JA, Shim JY, Kim SM, Lee HR (2007) Insulin resistance is associated with arterial stiffness independent of obesity in male adolescents. Hypertens Res 30:5–11

    PubMed  CAS  Google Scholar 

  104. Lee S, Bacha F, Arslanian SA (2006) Waist circumference, blood pressure, and lipid components of the metabolic syndrome. J Pediatr 149:809–816

    PubMed  CAS  Google Scholar 

  105. Lee SJ, Campos H, Moye LA, Sacks FM (2003) LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients. Arterioscler Thromb Vasc Biol 23:853–858

    PubMed  CAS  Google Scholar 

  106. Leeson CP, Whincup PH, Cook DG et al. (2000) Cholesterol and arterial distensibility in the first decade of life: a population-based study. Circulation 101:1533–1538

    PubMed  CAS  Google Scholar 

  107. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561–1566

    PubMed  CAS  Google Scholar 

  108. Lewis GF (1997) Fatty acid regulation of very low density lipoprotein production. Curr Opin Lipidol 8:146–153

    PubMed  CAS  Google Scholar 

  109. Li X, Li S, Ulusoy E, Chen W, Srinivasan SR, Berenson GS (2004) Childhood adiposity as a predictor of cardiac mass in adulthood: the Bogalusa Heart Study. Circulation 110:3488–3492

    PubMed  Google Scholar 

  110. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M (2006) Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 37:87–92

    PubMed  Google Scholar 

  111. Lurbe E, Torro I, Aguilar F et al. (2008) Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents. Hypertension 51:635–641

    PubMed  CAS  Google Scholar 

  112. Marcovina SM, Koschinsky ML, Albers JJ, Skarlatos S (2003) Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions. Clin Chem 49:1785–1796

    PubMed  CAS  Google Scholar 

  113. Marques-Vidal P, Bongard V, Ruidavets JB et al. (2003) Obesity and alcohol modulate the effect of apolipoprotein E polymorphism on lipids and insulin. Obes Res 11:1200–1206

    PubMed  CAS  Google Scholar 

  114. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419

    PubMed  CAS  Google Scholar 

  115. McCrindle BW, Urbina EM, Dennison BA et al. (2007) Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 115:1948–1967

    PubMed  Google Scholar 

  116. McGill HC Jr, McMahan CA, Herderick EE, Malcom GT, Tracy RE, Strong JP (2000) Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr 72:1307S–1315S

    PubMed  CAS  Google Scholar 

  117. McGill HC Jr, McMahan CA, Herderick EE et al. (2000) Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol 20:836–845

    PubMed  Google Scholar 

  118. McGill HC Jr, McMahan CA, Herderick EE et al. (2002) Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 105:2712–2718

    PubMed  Google Scholar 

  119. McGill HC Jr, McMahan CA, Zieske AW et al. (2000) Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 20:1998–2004

    PubMed  Google Scholar 

  120. McNamara JJ, Molot MA, Stremple JF, Cutting RT (1971) Coronary artery disease in combat casualties in Vietnam. JAMA 216:1185–1187

    PubMed  CAS  Google Scholar 

  121. McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ (2007) Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr 150:640–644, 644.e1

    PubMed  Google Scholar 

  122. Meyer AA, Kundt G, Lenschow U, Schuff-Werner P, Kienast W (2006) Improvement of early vascular changes and cardiovascular risk factors in obese children after a six-month exercise program. J Am Coll Cardiol 48:1865–1870

    PubMed  Google Scholar 

  123. Montagnani M, Quon MJ (2000) Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension. Diabetes Obes Metab 2:285–292

    PubMed  CAS  Google Scholar 

  124. Moran A, Jacobs DR Jr, Steinberger J et al. (2008) Changes in insulin resistance and cardiovascular risk during adolescence: establishment of differential risk in males and females. Circulation 117:2361–2368

    PubMed  CAS  Google Scholar 

  125. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH (1992) Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 327:1350–1355

    PubMed  CAS  Google Scholar 

  126. Nakashima Y, Fujii H, Sumiyoshi S, Wight TN, Sueishi K (2007) Early human ­atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings ­followed by macrophage infiltration. Arterioscler Thromb Vasc Biol 27:1159–1165

    PubMed  CAS  Google Scholar 

  127. Niboshi A, Hamaoka K, Sakata K, Inoue F (2006) Characteristics of brachial-ankle pulse wave velocity in Japanese children. Eur J Pediatr 165:625–629

    PubMed  Google Scholar 

  128. Nilsson PM, Engstrom G, Hedblad B et al. (2006) Plasma adiponectin levels in relation to carotid intima media thickness and markers of insulin resistance. Arterioscler Thromb Vasc Biol 26:2758–2762

    PubMed  CAS  Google Scholar 

  129. Olin-Lewis K, Krauss RM, La Belle M et al. (2002) ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan. J Lipid Res 43:1969–1977

    PubMed  CAS  Google Scholar 

  130. Olivieri O, Bassi A, Stranieri C et al. (2003) Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease. J Lipid Res 44:2374–2381

    PubMed  CAS  Google Scholar 

  131. Opie LH (2007) Metabolic syndrome. Circulation 115:e32–e35

    PubMed  Google Scholar 

  132. Orchard TJ, Temprosa M, Goldberg R et al. (2005) The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 142:611–619

    PubMed  CAS  Google Scholar 

  133. Ose L, Shah A, Davies MJ et al. (2006) Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis. Curr Med Res Opin 22:823–835

    PubMed  CAS  Google Scholar 

  134. Ouyang F, Christoffel KK, Brickman WJ et al. (2010) Adiposity is inversely related to insulin sensitivity in relatively lean Chinese adolescents: a population-based twin study. Am J Clin Nutr 91(3):662–671

    PubMed  Google Scholar 

  135. Paolini JF, Bays HE, Ballantyne CM et al. (2008) Extended-release niacin/laropiprant: reducing niacin-induced flushing to better realize the benefit of niacin in improving cardiovascular risk factors. Cardiol Clin 26:547–560

    PubMed  Google Scholar 

  136. Pavkov ME, Hanson RL, Knowler WC, Bennett PH, Krakoff J, Nelson RG (2007) Changing patterns of type 2 diabetes incidence among Pima Indians. Diab Care 30:1758–1763

    Google Scholar 

  137. Pilz S, Horejsi R, Moller R et al. (2005) Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab 90:4792–4796

    PubMed  CAS  Google Scholar 

  138. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P (1996) Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 128:608–615

    PubMed  CAS  Google Scholar 

  139. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB (2004) Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291:1730–1737

    PubMed  CAS  Google Scholar 

  140. Prins JB, Niesler CU, Winterford CM et al. (1997) Tumor necrosis factor-alpha induces apoptosis of human adipose cells. Diabetes 46:1939–1944

    PubMed  CAS  Google Scholar 

  141. Raitakari OT, Juonala M, Kahonen M et al. (2003) Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 290:2277–2283

    PubMed  CAS  Google Scholar 

  142. Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607

    PubMed  CAS  Google Scholar 

  143. Reinehr T, Kiess W, de Sousa G, Stoffel-Wagner B, Wunsch R (2006) Intima media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism 55:113–118

    PubMed  CAS  Google Scholar 

  144. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557–1565

    PubMed  CAS  Google Scholar 

  145. Ryden M, Arvidsson E, Blomqvist L, Perbeck L, Dicker A, Arner P (2004) Targets for TNF-alpha-induced lipolysis in human adipocytes. Biochem Biophys Res Commun 318:168–175

    PubMed  CAS  Google Scholar 

  146. Sacks FM, Alaupovic P, Moye LA et al. (2000) VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the cholesterol and recurrent events (CARE) trial. Circulation 102:1886–1892

    PubMed  CAS  Google Scholar 

  147. Sale MM, Woods J, Freedman BI (2006) Genetic determinants of the metabolic syndrome. Curr Hypertens Rep 8:16–22

    PubMed  CAS  Google Scholar 

  148. Savva SC, Tornaritis M, Savva ME et al. (2000) Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index. Int J Obes Relat Metab Disord 24:1453–1458

    PubMed  CAS  Google Scholar 

  149. Selvin E, Paynter NP, Erlinger TP (2007) The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 167:31–39

    PubMed  CAS  Google Scholar 

  150. Short KR, Blackett PR, Gardner AW, Copeland KC (2009) Vascular health in children and adolescents: effects of obesity and diabetes. Vasc Health Risk Manag 5:973–990

    PubMed  CAS  Google Scholar 

  151. Sinaiko AR, Steinberger J, Moran A et al. (2005) Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation 111:1985–1991

    PubMed  CAS  Google Scholar 

  152. Singhal A, Farooqi IS, Cole TJ et al. (2002) Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation 106:1919–1924

    PubMed  CAS  Google Scholar 

  153. Sinha R, Fisch G, Teague B et al. (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346:802–810

    PubMed  CAS  Google Scholar 

  154. Sivanandam S, Sinaiko AR, Jacobs DR Jr, Steffen L, Moran A, Steinberger J (2006) Relation of increase in adiposity to increase in left ventricular mass from childhood to young adulthood. Am J Cardiol 98:411–415

    PubMed  Google Scholar 

  155. Sniderman AD, Faraj M (2007) Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndrome. Curr Opin Lipidol 18:633–637

    PubMed  CAS  Google Scholar 

  156. Sorva R, Kuusi T, Dunkel L, Taskinen MR (1988) Effects of endogenous sex steroids on serum lipoproteins and postheparin plasma lipolytic enzymes. J Clin Endocrinol Metab 66:408–413

    PubMed  CAS  Google Scholar 

  157. Srinivasan SR, Bao W, Wattigney WA, Berenson GS (1996) Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: the Bogalusa Heart Study. Metabolism 45:235–240

    PubMed  CAS  Google Scholar 

  158. Srinivasan SR, Berenson GS (1995) Serum apolipoproteins A-I and B as markers of coronary artery disease risk in early life: the Bogalusa Heart Study. Clin Chem 41:159–164

    PubMed  CAS  Google Scholar 

  159. Srinivasan SR, Ehnholm C, Elkasabany A, Berenson GS (2001) Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: The Bogalusa Heart Study. Metabolism 50:696–702

    PubMed  CAS  Google Scholar 

  160. Srinivasan SR, Myers L, Berenson GS (2002) Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study. Diabetes 51:204–209

    PubMed  CAS  Google Scholar 

  161. ter Maaten JC, Voordouw JJ, Bakker SJ, Donker AJ, Gans RO (1999) Salt sensitivity correlates positively with insulin sensitivity in healthy volunteers. Eur J Clin Invest 29:189–195

    PubMed  Google Scholar 

  162. Teran-Garcia M, Bouchard C (2007) Genetics of the metabolic syndrome. Appl Physiol Nutr Metab 32:89–114

    PubMed  CAS  Google Scholar 

  163. Thompson A, Danesh J (2006) Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies. J Intern Med 259:481–492

    PubMed  CAS  Google Scholar 

  164. Tomiyasu K, Walsh BW, Ikewaki K, Judge H, Sacks FM (2001) Differential ­metabolism of human VLDL according to content of ApoE and ApoC-III. Arterioscler Thromb Vasc Biol 21:1494–1500

    PubMed  CAS  Google Scholar 

  165. Torti FM, Torti SV, Larrick JW, Ringold GM (1989) Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta. J Cell Biol 108:1105–1113

    PubMed  CAS  Google Scholar 

  166. Tounian P, Aggoun Y, Dubern B et al. (2001) Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 358:1400–1404

    PubMed  CAS  Google Scholar 

  167. Trayhurn P (2005) Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 184:285–293

    PubMed  CAS  Google Scholar 

  168. Trayhurn P, Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92:347–355

    PubMed  CAS  Google Scholar 

  169. Troiano RP, Flegal KM, Kuczmarski RJ, Campbell SM, Johnson CL (1995) Overweight prevalence and trends for children and adolescents. The National Health and Nutrition Examination Surveys, 1963 to 1991. Arch Pediatr Adolesc Med 149:1085–1091

    PubMed  CAS  Google Scholar 

  170. Tuomilehto J, Lindstrom J, Eriksson JG et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350

    PubMed  CAS  Google Scholar 

  171. Ulrich P, Cerami A (2001) Protein glycation, diabetes, and aging. Recent Prog Horm Res 56:1–21

    PubMed  CAS  Google Scholar 

  172. Urban M, Wojtkielewicz K, Glowinska B, Peczynska J (2005) Soluble thrombomodulin – a molecular marker of endothelial cell injury in children and adolescents with obesity. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 11:73–77

    PubMed  Google Scholar 

  173. Urbina EM, Gidding SS, Bao W, Pickoff AS, Berdusis K, Berenson GS (1995) Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study. Circulation 91:2400–2406

    PubMed  CAS  Google Scholar 

  174. Urbina EM, Williams RV, Alpert BS et al. (2009) Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension 54:919–950

    PubMed  CAS  Google Scholar 

  175. Utermann G, Duba C, Menzel HJ (1988) Genetics of the quantitative Lp(a) lipoprotein trait. II. Inheritance of Lp(a) glycoprotein phenotypes. Hum Genet 78:47–50

    PubMed  CAS  Google Scholar 

  176. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C (1987) Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 80:458–465

    PubMed  CAS  Google Scholar 

  177. van Popele NM, Bos WJ, de Beer NA et al. (2000) Arterial stiffness as underlying mechanism of disagreement between an oscillometric blood pressure monitor and a sphygmomanometer. Hypertension 36:484–488

    PubMed  Google Scholar 

  178. Vincent S, Planells R, Defoort C et al. (2002) Genetic polymorphisms and lipoprotein responses to diets. Proc Nutr Soc 61:427–434

    PubMed  CAS  Google Scholar 

  179. Walldius G, Jungner I (2004) Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Intern Med 255:188–205

    PubMed  CAS  Google Scholar 

  180. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E (2001) High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358:2026–2033

    PubMed  CAS  Google Scholar 

  181. Wang B, Jenkins JR, Trayhurn P (2005) Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-alpha. Am J Physiol Endocrinol Metab 288:E731–E740

    PubMed  CAS  Google Scholar 

  182. Wang CS, McConathy WJ, Kloer HU, Alaupovic P (1985) Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest 75:384–390

    PubMed  CAS  Google Scholar 

  183. Wang W, Lee ET, Alaupovic P, Blackett P, Blevins KS (2005) Correlation between lipoprotein(a) and other risk factors for cardiovascular disease and diabetes in Cherokee Indians: the Cherokee Diabetes Study. Ann Epidemiol 15:390–397

    PubMed  Google Scholar 

  184. Wang X, Poole JC, Treiber FA, Harshfield GA, Hanevold CD, Snieder H (2006) Ethnic and gender differences in ambulatory blood pressure trajectories: results from a 15-year longitudinal study in youth and young adults. Circulation 114:2780–2787

    PubMed  Google Scholar 

  185. Wang XL, Wang J (2003) Lipoprotein(a) in children and adolescence. Pediatr Endocrinol Rev 1:109–119

    PubMed  Google Scholar 

  186. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796–1808

    PubMed  CAS  Google Scholar 

  187. Weiss R, Dufour S, Groszmann A et al. (2003) Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation. J Clin Endocrinol Metab 88:2014–2018

    PubMed  CAS  Google Scholar 

  188. West KM (1974) Diabetes in American Indians and other native populations of the New World. Diabetes 23:841–855

    PubMed  CAS  Google Scholar 

  189. Whincup PH, Gilg JA, Donald AE et al. (2005) Arterial distensibility in adolescents: the influence of adiposity, the metabolic syndrome, and classic risk factors. Circulation 112:1789–1797

    PubMed  CAS  Google Scholar 

  190. Williams KJ, Tabas I (1995) The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15:551–561

    PubMed  CAS  Google Scholar 

  191. Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB (2002) Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 162:1867–1872

    PubMed  Google Scholar 

  192. Woo KS, Chook P, Yu CW et al. (2004) Overweight in children is associated with ­arterial endothelial dysfunction and intima-media thickening. Int J Obes Relat Metab Disord 28:852–857

    PubMed  CAS  Google Scholar 

  193. Wunsch R, de Sousa G, Toschke AM, Reinehr T (2006) Intima-media thickness in obese children before and after weight loss. Pediatrics 118:2334–2340

    PubMed  Google Scholar 

  194. Young JB (1988) Effect of experimental hyperinsulinemia on sympathetic nervous ­system activity in the rat. Life Sci 43:193–200

    PubMed  CAS  Google Scholar 

  195. Yu WC, Chuang SY (2007) Lin YP. Brachial-ankle vs carotid-femoral pulse wave velocity as a determinant of cardiovascular structure and function. J Hum Hypertens, Chen CH

    Google Scholar 

  196. Yusuf S, Hawken S, Ounpuu S et al. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937–952

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diabetes and Endocrinology Section, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

    Piers R. Blackett MB, ChB

Authors
  1. Piers R. Blackett MB, ChB
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Petar Alaupovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kevin Short
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kenneth C. Copeland
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. UT Health Science Center at Memphis, Division of Pediatric Endocrinology and, Le Bonheur Children's Hospital, North Dunlap Street 50, Memphis, 38103, Tennessee, USA

    Robert J. Ferry, Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Blackett, P.R., Alaupovic, P., Short, K., Copeland, K.C. (2011). Assessment and Treatment of Cardiovascular Disease in Obese Children. In: Ferry, Jr., R. (eds) Management of Pediatric Obesity and Diabetes. Nutrition and Health. Humana Press. https://doi.org/10.1007/978-1-60327-256-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-256-8_5

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-255-1

  • Online ISBN: 978-1-60327-256-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation